publication venue for
- Does HIV infection of B lymphocytes initiate AIDS lymphoma? Detection by PCR of viral sequences in lymphoma tissue.. 182. 1992
- Mechanism of negative feed-back regulation of c-myc gene expression in B-cells and its inactivation in tumor cells.. 166. 1990
- Different biological effects of c-myc and H-ras oncogene expression in EBV-infected human lymphoblasts.. 141. 1988
- Immunological probes in the analysis of myc protein expression.. 141. 1988
- Cancer drug development. Preface.. 355. 2012
- Adjuvants. 2020
- Adapting Secretory Proteostasis and Function Through the Unfolded Protein Response. 2018
- Animal models for hepatitis C. 2013
- Innate immune responses to hepatitis C virus. 2013
- Mycobacterium tuberculosis metabolism and host interaction: mysteries and paradoxes. 2013
- JAK-mutant myeloproliferative neoplasms. 2012
- Will kinase inhibitors make it as glioblastoma drugs? 2012
- Angiogenesis and the tumor vasculature as antitumor immune modulators: the role of vascular endothelial growth factor and endothelin. 2011
- Monoclonal antibody therapy of APL. 2007
- Targeting APL fusion proteins by peptide interference. 2007
- Type I interferon in systemic lupus erythematosus. 2007
- Molecular mimicry: anti-DNA antibodies bind microbial and nonnucleic acid self-antigens. 2005
- The role of TCR specificity in naturally arising CD25+ CD4+ regulatory T cell biology. 2005
- Mechanisms of virus neutralization by antibody. 2001
- Molecular pathogenesis of B-cell chronic lymphocytic leukemia: analysis of 13q14 chromosomal deletions. 2000
- Receptor modulators of B-cell receptor signalling--CD19/CD22. 2000
- Diphtheria toxin fusion proteins. 1998
- Inducible nitric oxide synthase: regulation subserves function. 1995
- Regulation of terminal differentiation of human B-cells by IL-6. 1995
- Stress-induced proteins in immune response to cancer. 1991
- The fibroblast growth factors: an emerging family of neural growth factors. 1991
- Complement receptor type 1 (C3b/C4b receptor; CD35) and complement receptor type 2 (C3d/Epstein-Barr virus receptor; CD21). 1990
- Cross-reactivity between streptococcus and human tissue: a model of molecular mimicry and autoimmunity. 1989
- Genetic control of the susceptibility to infection with pathogenic bacteria. 1986